Drug safety watch: Real-World kidney disease treatment under scrutiny

NCT ID NCT06287073

Summary

This study monitored the safety and effectiveness of Jardiance (empagliflozin) in Korean patients with chronic kidney disease during routine medical care. Researchers tracked side effects and measured kidney health markers in 299 patients over 24 weeks. The goal was to understand how well the medication works and what side effects occur in everyday clinical practice.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY DISEASE, CHRONIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Chonnam National University Hospital

    Gwangju, 61469, South Korea

  • Chungbuk National University Hospital

    Cheongiu, 28644, South Korea

  • Hallym University Sacred Heart Hospital

    Anyang, 07441, South Korea

  • Inje University Ilsan Paik Hospital

    Goyang, 10380, South Korea

  • Korea University Anam Hospital

    Seoul, 02841, South Korea

  • Samsung Medical Center

    Seoul, 06351, South Korea

  • Seoul National University Hospital

    Seoul, 03080, South Korea

  • Soonchunhyang University Hospital Seoul

    Seoul, 04401, South Korea

  • The Catholic University of Korea, Eunpyeong St. Mary's Hospital

    Seoul, 03312, South Korea

  • The Catholic University of Korea, Yeouido St.Mary's Hospital

    Seoul, 07345, South Korea

  • Ulsan University Hospital

    Ulsan, 44033, South Korea

  • Yonsei University Wonju Severance Christian Hospital

    Gangwon, 26426, South Korea

Conditions

Explore the condition pages connected to this study.